To investigate the role of Notch signaling in CHCHD2 overexpression–induced liver fibrosis in NASH mice, we treated mice with the Notch inhibitor DAPT (Figure 7A). Here, CHCHD2 is linked to metabolic dysfunction-associated steatohepatitis.